JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB144650

Pitstop® 2-100, clathrin terminal domain inhibitor

Be the first to review this product! Submit a review

|

(2 Publications)

MW 463.35 g/mol, Purity >99%. Novel clathrin terminal domain inhibitor (IC50 = 7.5 μM). Specifically inhibits the internalisation of major histocompatibility complex 1 (MHC1). Related products Pitstop® 2 (ab120687), Pitstop® 1 (ab120686) and Pitstop® 1-25 (ab144651).
1 Images
Chemical Structure - Pitstop® 2-100, clathrin terminal domain inhibitor (AB144650)
  • Chemical Structure

Lab

Chemical Structure - Pitstop® 2-100, clathrin terminal domain inhibitor (AB144650)

2D chemical structure image of ab144650, Pitstop® 2-100, clathrin terminal domain inhibitor

Key facts

Purity

>99%

Form

Solid

form

Molecular weight

463.35 g/mol

Nature

Synthetic

Solubility

Soluble in DMSO

Biological description

Novel clathrin terminal domain inhibitor (IC50 = 7.5 μM). Specifically inhibits the internalisation of major histocompatibility complex 1 (MHC1). Related products Pitstop® 2 (ab120687), Pitstop® 1 (ab120686) and Pitstop® 1-25 (ab144651).

Isomeric smiles

O=C4N=C(NS(=O)(=O)C2CCCC1CCCCC12)S\C4=C/C3CC(CL)CC(CL)C3

InChi

InChI=1S/C20H12Cl2N2O3S2/c21-14-8-12(9-15(22)11-14)10-17-19(25)23-20(28-17)24-29(26,27)18-7-3-5-13-4-1-2-6-16(13)18/h1-11H,(H,23,24,25)/b17-10-

InChiKey

LSNZIDXWMYTGMW-YVLHZVERSA-N

IUPAC Name

(Z)-N-[5-(3,5-Dichlorobenzylidene)-4-oxo-4,5-dihydrothiazol-2-yl]naphthalene-1-sulfonamide

Product details

Sold under exclusive licence from Children's Medical Research Institute and Newcastle Innovation Ltd. Pitstop® is a trademark of Freie Universitat Berlin, Newcastle Innovation Ltd. and Children's Medical Research Institute.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Cellular & molecular immunology 20:264-276 PubMed36600053

2023

The neuropeptide CGRP enters the macrophage cytosol to suppress the NLRP3 inflammasome during pulmonary infection.

Applications

Unspecified application

Species

Unspecified reactive species

Fangrui Zhu,Dou Yu,Xiwen Qin,Yan Qian,Juan Ma,Weitao Li,Qiannv Liu,Chunlei Wang,Yan Zhang,Yi Li,Dong Jiang,Shuo Wang,Pengyan Xia

Molecular psychiatry : PubMed35484240

2022

Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Abdel Ali Belaidi,Shashank Masaldan,Adam Southon,Pawel Kalinowski,Karla Acevedo,Ambili T Appukuttan,Stuart Portbury,Peng Lei,Puja Agarwal,Sue E Leurgans,Julie Schneider,Marcus Conrad,Ashley I Bush,Scott Ayton
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com